One of the few drug trials for a possible long Covid ended in disappointment. But lessons are leading to a second chance.

Transforming breakthrough scientific innovation into real-world impact requires perseverance, passion, and support from a ...

Sarilumab enhanced QoL and symptom relief in individuals with polymyalgia rheumatica who struggled with standard ...

A new international study found that a four-day workweek with no loss of pay significantly improved worker well-being, ...

Frailty is highly prevalent among patients with vasculitis and is associated with adverse health outcomes and reduced HRQOL.

Chronic fatigue syndrome. Read the latest research news on chronic fatigue syndrome (CFS).